×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ACRV – acrivon therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ACRV
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/29
01:34 am
acrv
H.C. Wainwright Initiates Coverage on Acrivon Therapeutics (ACRV) With “Buy” Rating and $19 PT [Yahoo! Finance]
Low
Report
H.C. Wainwright Initiates Coverage on Acrivon Therapeutics (ACRV) With “Buy” Rating and $19 PT [Yahoo! Finance]
11/25
08:07 am
acrv
Acrivon Therapeutics (NASDAQ:ACRV) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Low
Report
Acrivon Therapeutics (NASDAQ:ACRV) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
10/22
05:23 pm
acrv
Acrivon Therapeutics Highlights its Powerful Generative Phosphoproteomics AP3 Platform with Compelling Preclinical Data for ACR-2316 with Three Presentations at the Upcoming AACR-NCI-EORTC International Conference [Yahoo! Finance]
Low
Report
Acrivon Therapeutics Highlights its Powerful Generative Phosphoproteomics AP3 Platform with Compelling Preclinical Data for ACR-2316 with Three Presentations at the Upcoming AACR-NCI-EORTC International Conference [Yahoo! Finance]
10/22
04:15 pm
acrv
Acrivon Therapeutics Highlights its Powerful Generative Phosphoproteomics AP3 Platform with Compelling Preclinical Data for ACR-2316 with Three Presentations at the Upcoming AACR-NCI-EORTC International Conference
Low
Report
Acrivon Therapeutics Highlights its Powerful Generative Phosphoproteomics AP3 Platform with Compelling Preclinical Data for ACR-2316 with Three Presentations at the Upcoming AACR-NCI-EORTC International Conference
10/3
02:37 pm
acrv
Acrivon Therapeutics (NASDAQ:ACRV) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Acrivon Therapeutics (NASDAQ:ACRV) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
10/1
04:51 pm
acrv
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/25
04:04 pm
acrv
Form 4 Acrivon Therapeutics, For: Nov 21 Filed by: Blume-Jensen Peter
Low
Report
Form 4 Acrivon Therapeutics, For: Nov 21 Filed by: Blume-Jensen Peter
11/21
05:37 pm
acrv
Form SCHEDULE 13G Acrivon Therapeutics, Filed by: CITADEL ADVISORS LLC
Low
Report
Form SCHEDULE 13G Acrivon Therapeutics, Filed by: CITADEL ADVISORS LLC
11/18
04:34 pm
acrv
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Peterson Katharine
Low
Report
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Peterson Katharine
11/18
04:32 pm
acrv
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Miller Mary
Low
Report
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Miller Mary
11/18
04:31 pm
acrv
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Gamelin Erick
Low
Report
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Gamelin Erick
11/18
04:30 pm
acrv
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Devroe Eric
Low
Report
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Devroe Eric
11/18
04:29 pm
acrv
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Blume-Jensen Peter
Low
Report
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Blume-Jensen Peter
11/14
04:10 pm
acrv
Form SCHEDULE 13G/A Acrivon Therapeutics, Filed by: CITADEL ADVISORS LLC
Medium
Report
Form SCHEDULE 13G/A Acrivon Therapeutics, Filed by: CITADEL ADVISORS LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: